Related Experiment Video
Updated: Jan 23, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Safety in numbers: Identifying multiple targets for beta cell proliferation
1Department of Medicine and Molecular Pharmacology, The "Norman Fleischer" Institute for Diabetes and Metabolism, Albert Einstein College of Medicine, New York, NY 10461, USA; Department of Advanced Biomedical Sciences, "Federico II" University, Naples 80131, Italy.
Abstract:
Combined inhibition of DYRK1A and TGF-β pathways synergistically enhances proliferation and differentiation of human pancreatic beta cells.
Insights
Combined inhibition of dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) and transforming growth factor-beta (TGF-β) pathways boosts human pancreatic beta cell growth and function. This finding offers new therapeutic avenues for diabetes.
Area of Science:
- Endocrinology
- Cell Biology
- Molecular Biology
Background:
- Pancreatic beta cells are crucial for glucose homeostasis.
- Dysfunction of beta cells contributes to diabetes mellitus.
- Targeting specific signaling pathways is a key strategy for beta cell regeneration.
Purpose of the Study:
- To investigate the synergistic effects of inhibiting DYRK1A and TGF-β pathways on human pancreatic beta cells.
- To explore potential therapeutic strategies for enhancing beta cell mass and function.
Main Methods:
- Human pancreatic islets were cultured in vitro.
- Cells were treated with specific inhibitors for DYRK1A and TGF-β pathways.
- Cell proliferation and differentiation markers were assessed using quantitative PCR and immunofluorescence.
Main Results:
- Combined inhibition of DYRK1A and TGF-β pathways significantly increased beta cell proliferation compared to single-pathway inhibition.
- The combined treatment also enhanced markers of beta cell differentiation and function.
- No significant toxicity was observed at effective concentrations.
Conclusions:
- Simultaneous blockade of DYRK1A and TGF-β signaling represents a potent strategy to promote human beta cell expansion and maturation.
- This dual-targeting approach holds promise for regenerative medicine in diabetes treatment.
Related Concept Videos
Multiple Allele Traits
Survey Safety
Cells Coordinate Growth and Proliferation
Abnormal Proliferation
Household Wiring And Electrical Safety
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...

